Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Fludarabine Phosphate in Metastatic castration-resistant prostate cancer: NCT07803653 Clinical Landscape Report 2026
11 September 2026
NCT07803653 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
DT-7012 in Locally Advanced Soft Tissue Sarcoma: NCT07802652 Clinical Landscape Report 2026
11 September 2026
NCT07802652 clinical landscape for Locally Advanced Soft Tissue Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
GB-0895 in Severe asthma: NCT07359846 Clinical Landscape Report 2026
11 September 2026
NCT07359846 clinical landscape for Severe asthma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Toripalimab in Renal Cell Carcinoma: NCT07744932 Clinical Landscape Report 2026
11 September 2026
NCT07744932 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRS-4139 in Psoriasis vulgaris: NCT07802964 Clinical Landscape Report 2026
11 September 2026
NCT07802964 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Pancreatic adenocarcinoma: NCT07808567 Clinical Landscape Report 2026
11 September 2026
NCT07808567 clinical landscape for Pancreatic adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
[18F]-D2-deprenyl in Multiple Sclerosis: NCT07805473 Clinical Landscape Report 2026
11 September 2026
NCT07805473 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lidocaine in Analgesia: NCT07809425 Clinical Landscape Report 2026
11 September 2026
NCT07809425 clinical landscape for Analgesia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tumor-Targeted Drug Conjugate(TwoStep) in Ovarian Cancer: NCT07814248 Clinical Landscape Report 2026
11 September 2026
NCT07814248 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CS1-targeted autologous CAR-T cells (Hematology Hospital of Chinese Academy of Medical Sciences) in Relapse multiple myeloma: NCT07809594 Clinical Landscape Report 2026
11 September 2026
NCT07809594 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TUB-040 in Metastatic Non-Squamous Non-Small Cell Lung Carcinoma: NCT07806773 Clinical Landscape Report 2026
11 September 2026
NCT07806773 clinical landscape for Metastatic Non-Squamous Non-Small Cell Lung Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and d…
9 min read
C-CAR168 in Neuromyelitis Optica: NCT07676266 Clinical Landscape Report 2026
11 September 2026
NCT07676266 clinical landscape for Neuromyelitis Optica: endpoints, sponsor, phase, geography, readouts, asset context and development white space.